Microtubule and MAPs: thermodynamics of complex formation by AUC, ITC, fluorescence, and NMR. by Devred, François et al.
HAL Id: hal-00508818
https://hal.archives-ouvertes.fr/hal-00508818
Submitted on 28 Jul 2017
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Microtubule and MAPs: thermodynamics of complex
formation by AUC, ITC, fluorescence, and NMR.
François Devred, Pascale Barbier, Daniel Lafitte, Isabelle Landrieu, Guy
Lippens, Vincent Peyrot
To cite this version:
François Devred, Pascale Barbier, Daniel Lafitte, Isabelle Landrieu, Guy Lippens, et al.. Microtubule
and MAPs: thermodynamics of complex formation by AUC, ITC, fluorescence, and NMR.. Methods
in Cell Biology, Elsevier, 2010, 95, pp.449-480. ￿10.1016/S0091-679X(10)95023-1￿. ￿hal-00508818￿
CHAPTER 23
Microtubule and MAPs: Thermodynamics
of Complex Formation by AUC, ITC,
Fluorescence, and NMR
François Devred*, Pascale Barbier*, Daniel Lafitte*, Isabelle
Landrieu†, Guy Lippens†, and Vincent Peyrot*
*CRO2, U911 Inserm, Aix-Marseille Universite, 27 Bd Jean Moulin, 13385 Marseille cedex 05, France
†CNRS-UMR 8576 UGSF-IFR 147, Universite des Sciences et Technologies de Lille 1, 59655 Villeneuve
d’Ascq Cedex, France
Abstract
I. Introduction
II. Rationale
III. Materials and Methods
A. Protein Purification and Sample Preparation
B. Analytical Ultracentrifugation
C. Co-sedimentation Assay
D. Fluorescence or Förster Energy Transfer (FRET)
E. Microcalorimetry (ITC)
F. NMR Spectroscopy Involving Tubulin
IV. Discussion
A. Evidences of MAP–Tubulin and Microtubules Complexes Formation
B. Thermodynamic Parameters Determination of MAP–Tubulin Interaction
C. Detailing the MAP–MT Interface: NMR
V. Concluding Remarks
Acknowledgments
References
Abstract
Microtubules are implicated in many essential cellular processes such as archi-
tecture, cell division, and intracellular traffic, due to their dynamic instability. This
dynamicity is tightly regulated by microtubule-associated proteins (MAPs), such as
METHODS IN CELL BIOLOGY, VOL. 95 978-0-12-374815-7
Copyright  2010 Elsevier Inc. All rights reserved. 449 DOI: 10.1016/S0091-679X(10)95023-1
tau and stathmin. Despite extensive studies motivated by their central role in
physiological functions and pathological role in neurodegenerative diseases and
cancer, the precise mechanisms of tau and stathmin binding to tubulin and their
consequences on microtubule stability are still not fully understood. One of the most
crucial points missing is a quantitative thermodynamic description of their interac-
tion with tubulin/microtubules and of the tubulin complexes formed upon these
interactions. In this chapter, we will focus on the use of analytical ultracentrifugation,
isothermal titration calorimetry, and nuclear magnetic resonance—three powerful
and complementary techniques in the field of MAP–tubulin/microtubule interac-
tions, in addition to the spectrometric techniques and co-sedimentation approach. We
will present the limits of these techniques to study this particular interaction and
precautions that need to be taken during MAPs preparation. Understanding the
molecular mechanisms that govern MAPs action on microtubular network will not
only shed new light on the role of this crucial family of protein in the biology of the
cell, but also hopefully open new paths to increase the therapeutic efficiency of
microtubule-targeting drugs in cancers therapies and neurodegeneratives diseases
prevention.
I. Introduction
The microtubule cytoskeleton is a very dynamic network that plays a crucial role
in many cellular processes such as cellular architecture, cell division, and intracel-
lular traffic. Microtubules (MTs) are implicated in all of these processes because of
their ability to constantly switch from polymerization to depolymerization, a phe-
nomenon known as dynamic instability, which enables their structural rearrange-
ment, and reactivity to cellular signaling. Microtubules and their functions are tightly
regulated by a great number of proteins known as microtubule-associated proteins
(MAPs), which can bind to free tubulin and/or to MTs. MAPs can be divided in two
groups depending on their activity on MT formation. Stabilizing MAPs, such as tau,
preferentially bind to MTs and favor their polymerization, whereas destabilizing
MAPs, such as stathmin, bind to both free tubulin and MTs, promoting MT depo-
lymerization. Tau and stathmin are the two most studied MAPs because of their
central role in physiological functions and also because of their implications in
neurodegenerative diseases and cancer.
Tau is a MAP that stabilizes axonal microtubules and maintains neuronal pro-
cesses (Cleveland et al., 1977). Human brain expresses six tau isoforms that are
generated from a single gene by alternative mRNA splicing. The longest four-repeat
441 amino acids isoform of tau, htau40, was used throughout our biophysical
studies. Beyond its physiological role as a MT-stabilizing protein, tau is also
known to play a major role in Alzheimer disease (Trojanowski and Lee, 2002).
Upon phosphorylation, tau detaches from microtubules and, after subsequent hyper-
phosphorylation, aggregates into pathological paired helical filaments (PHFs). Even
though many kinases-targeting tau have been discovered and multiple phosphoryla-
tion sites studied (Biernat et al., 1992; Goedert et al., 1994; Goedert et al., 1995;
Hasegawa et al., 1992; Hoffmann et al., 1997; Mercken et al., 1992; Zheng-
Fischhofer et al., 1998), the precise mechanisms of tau dissociation from MTs and
subsequent aggregation are still not fully understood. Several models have been
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proposed to explain how tau proteins interact with MTs, using different stoichiome-
try, binding affinity, and geometry of tau. In addition to the fact that no unifying
scheme has been proposed, the quantification of the influence of other factors, such
as the oxidation state of the two cysteines of tau in addition to its posttranslational
modification by phosphorylation, remains challenging.
Stathmin, also designated as oncoprotein 18 among other names, is a MAP that
destabilizes microtubules and plays a role in many cellular processes including
migration and cell division. Stathmin and related protein family members that
share the same stathmin-like domain (SLD), such as RB3, promote MT depolymer-
ization by increasing the catastrophe rate of MTs (transition from a state of poly-
merization to a state of depolymerization) and by sequestering free tubulin, thus
lowering the pool of “assembly competent” tubulin (Charbaut et al., 2001). Stathmin
activity/binding to tubulin is also tightly regulated by phosphorylation. For example,
during cell division, as cells enter mitosis, stathmin is inactivated by phosphorylation
allowing microtubules to form the mitotic spindle. As cells exit mitosis, stathmin is
activated by dephosphorylation, leading to depolymerization of the mitotic spindle
and proper separation of the daughter cells. Over the past 20 years it has been shown
that stathmin is expressed at high levels in a wide variety of human cancers,
including breast cancer, leukemia, lymphoma, prostate, and ovarian carcinoma
(Curmi et al., 2000; Friedrich et al., 1995; Ghosh et al., 2007; Price et al., 2000)
suggesting that it could play a role in tumor progression. Furthermore, several
studies have shown a correlation between the level of expression of stathmin in
cancer cells and their sensitivity to microtubule-targeting agents (Alli et al., 2002;
Alli et al., 2007a,b; Iancu et al., 2000; Martello et al., 2003; Mistry et al., 2007; Xi
et al., 2009). Despite all these clinical and cellular studies, there is no clear under-
standing of the exact role of this MAP in tumor progression and in tumor cells
sensitivity to anticancer drugs. Significant progress has been made in the under-
standing of stathmin interaction to tubulin with the resolution of the T2S complex
(two molecules of tubulin and one stathmin) structure by X-ray crystallography
(Gigant et al., 2000). Even though it confirmed the stoichiometry of the T2S
complex and validated the model, this structure did not, however, answer all the
questions about stathmin–tubulin interaction thermodynamics.
Binding of both tau and stathmin to MTs plays a pivotal role in both pathological
and physiological processes. Understanding the mechanisms of MAPs requires a
quantitative description of the interaction of tubulin and/or microtubules with MAPs
in different states of phosphorylation, and of the effects of these MAPs in the
different states of MT dynamics. This chapter will focus on the methods that we
have used to measure the thermodynamic parameters of the interaction of tau or
stathmin with tubulin. These methods enabled us to generate new insights into how
MAPs interact with tubulin and/or MTs at the molecular level and to address the
following questions. What are the consequences of MAP binding on the oligomeric
state of tubulin? What is the nature of the interaction between MT and its MAPs?
How is this interaction regulated and which regions of the proteins are involved?
Understanding the molecular mechanisms that govern MAPs action on MT net-
work will not only shed new light on the role of this crucial family of proteins in the
biology of the cell, but also hopefully open new avenues to increase the therapeutic
efficacy of microtubule-targeting drugs in cancer therapies and neurodegenerative
disease prevention.
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II. Rationale
Various methods are routinely used to measure the thermodynamic parameters of
complexes formation between two proteins in solution; each method having its pros
and cons depending on the stability of the complex and on the nature of the
information that we are seeking. Measure of thermodynamic parameters relies on
being able to follow the formation of a complex, which often means distinguishing
between free or bound ligand and tubulin.
It is important to remember that an accurate description of the percentage of
complexes formed thereby is only possible when the absolute concentrations of
both partners are of the same order of magnitude than the dissociation constant
(Kd). Nevertheless, even in those borderline cases, the methods can indicate changes
in affinity caused by different parameters. In the following paragraphs, we will detail
several biophysical methods to detect and characterize the MAP/tubulin complexes,
and shed further light on the information they can yield but equally on their (dis)
advantages and limits.
All proteins absorb UV light in the range of 190–240 nm (peptide bond) and some
with aromatic residues absorb around 280 nm. Aromatic rings in proteins also lead to
intrinsic fluorescence emission (emission wavelength from 300 to 350 nm), which is
highly dependent upon polarity and/or local environment. However, changes in
intrinsic fluorescence due to protein/protein interactions are generally small, as
they implicate only those aromatics directly involved in the interface, and are
hence not easy to analyze. One strategy to eliminate this problem is to use a
fluorophore with unique absorption or emission characteristics to label one partner,
and to use changes in the fluorescence of this label to detect binding. Other
physicochemical properties can be used to differentiate between bound and free
proteins. In this chapter, we will focus our study on analytical ultracentrifugation
(AUC), isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR),
three powerful and complementary techniques in the field of MAP–MT interactions.
We will also briefly discuss a spectrometric fluorescence or Förster resonance energy
transfer (FRET) approach and co-sedimentation.
AUC supplies useful information on the size and shape of macromolecules in
solution with very few constraints on the sample or the nature of the solvent. Some
of the thermodynamic parameters measured by AUC include the molecular weight,
association state, and equilibrium constants for reversibly interacting systems. More-
over, for samples containing many components or aggregates as well as high
concentration samples, size distributions and average quantities may be measured
and characterized. This tool is particularly suited for the study of tubulin and its
partners, and comes as a valuable complement to electron microscopy. Since all
MAPs change the assembly state of tubulin, AUC is usually the first step when
studying a new MAP–tubulin binding reaction. From AUC, two complementary
views of macromolecules in solution behavior are accessible: (1) sedimentation
velocity gives essential hydrodynamic information about the size and shape of
molecules and (2) sedimentation equilibrium provides extra thermodynamic knowl-
edge about the solution molar masses, stoichiometry, and association constants. For
all these reasons, AUC is one of the most useful and well-established technique
widely used in the field of tubulin biochemistry. Indeed, AUC was extensively used
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with tubulin and was responsible for major breakthroughs concerning the formation
of the tubulin network. In the beginning of the seventies, the polymorphism of
polymerization and depolymerization of microtubules has been largely exemplified
by the pioneers’ work of Borisy (Borisy et al., 1972). Using the famous “Beckman
Model E,” they extensively characterized the equilibrium between a 6S tubulin dimer
species and 20–30S oligomers species (Borisy et al., 1972; Marcum and Borisy,
1978; Scheele and Borisy, 1978; Vallee and Borisy, 1978). At the end of these
studies it was finally concluded that the formation of oligomeric species was
promoted by high molecular weight proteins, which turned out to be what we now
call MAPs. In 1974, Frigon et al., using electron microscopy and AUC, observed
with pure tubulin in presence of magnesium ion that the 6S tubulin dimer peak was
in equilibrium with a 36S faster peak constituted of ring tubulin oligomers (Frigon
et al., 1974). Then, Frigon and Timasheff, in two major publications, fully char-
acterized the molecular mechanism of magnesium ion induced self-association of
pure tubulin (Frigon and Timasheff, 1975a,b). The role of GDP in the self-assembly
of tubulin into various structures was probed by sedimentation velocity (Howard and
Timasheff, 1986). Later, in the eighties, Timasheff’s group used AUC to study the
ligand binding linked to tubulin self-association. The technique was also particularly
successful in the study of the binding of the vinca alkaloids (vinblastine, vincristine,
catharanthine) to tubulin (Na and Timasheff, 1980a,b; Na and Timasheff, 1986a,b). It
was further developed in Correia’s team, who analyzed thermodynamic data from
many vinca alcaloid and analogues: from classical family members such as vinor-
elbine and vinflunine to new compounds such as eribulin (Alday and Correia, 2009;
Chatterjee et al., 2001; Lobert and Correia, 2007; Lobert et al., 1998).
In our laboratory, we used AUC to address the question of the oligomerization
state of HSP90 (Garnier et al., 2002) as well as the interaction between cytochrome
C3 type I and II (Pieulle et al., 2005), but most of all, we used it to study tubulin. We
analyzed the ring formation process after C-terminal cleavage of both a and b
tubulin chains by subtilisin (Peyrot et al., 1990; Peyrot et al., 1991) as well as ring
formation induced by cryptophycin 52 (Barbier et al., 2001). Lately we have been
applying AUC to the interaction between tau and microtubules (Devred et al., 2004)
and also, along with microcalorimetry techniques, on stathmin–tubulin interactions
(Devred et al., 2008) as we will discuss in the last section.
Once the oligomeric states of tubulin/MAP complexes are known, other methods
can be used for the full characterization of their interaction. A full thermodynamic
characterization of a binding reaction means the determination of the free energy
change, DG, the enthalpy change, DH, and the entropy change, DS. DH and Ka are
measured or fitted to experimental data, and DG and DS, can be easily calculated
from DH and Ka using the following relationships:
DG ¼ RT ln Ka ð1Þ
DH ¼ R dðln KaÞ
dð1=TÞ ð2Þ
DS ¼ R dðln KaÞ
dðln TÞ ¼
DHDG
T
ð3Þ
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It is also valuable, as we will see, to measure the change in heat capacity at constant
pressure,
DCp ¼ dDHdT
 
ð4Þ
In fact, DH is best measured directly by calorimetry. Microcalorimetry, based on the
exchanges of heat accompanying the interaction between two (macro)molecules, was
first described as a method for the simultaneous determination of binding constant
(Ka) and enthalpy variation (DH), 40 years ago (Christensen et al., 1966). A
calorimeter measures the heat taken up from the environment (endothermic process)
or heat given up to the environment (exothermic process). In contrast to spectro-
scopic methods, calorimetric measurements can be used to measure the interaction
between molecules that are “spectroscopically silent” (no chromophore nor fluor-
ophore tag is required), or in buffer conditions that would render spectroscopic
measurement difficult to interpret (turbid, opaque, UV absorbing or heterogeneous
solutions).
Over time, our laboratory has gained considerable experience with ITC to char-
acterize the thermodynamics of various protein/ligand complexes. As examples, we
measured the thermodynamic parameters of the interaction between: cephalosporins
and human serum albumin (Briand et al., 1982); methotrexate and some of its
metabolites with dihydrofolate reductase (Gilli et al., 1988) and thymidylate
synthase (Gilli et al., 1990); Ca2þ, Mg2þ, and calmodulin (Gilli et al., 1998);
coumarins and gyrase fragment (Lafitte et al., 2002); vinca alkaloid and calmodulin
(Makarov et al., 2007).
Recently this technique has been used to characterize the binding of stathmin to
tubulin (Honnappa et al., 2003). We thus used it to study the influence of antimitotic
drugs on the binding of stathmin to tubulin. ITC enabled us to show that vinblastine
significantly increases stathmin affinity for tubulin and that stathmin has the same
effect on the vinblastine binding constant for tubulin (Devred et al., 2008). ITC is a
very powerful tool to obtain a quick and reliable comparison of the thermodynamic
parameters of interaction of two molecules in solution, but it does not give any
information on the nature of the species in solution. This is why it is usually coupled
to AUC or electron microscopy.
Beside ITC and AUC, one of the most commonly used indirect binding methods is
the change of the ligand fluorescence on binding and the quenching of the intrinsic
protein fluorescence. Let us recall that data interpretation of spectral methods
typically depends on a priori assumptions that there is a correlation between the
spectral changes and the amount of the ligand bound (Bujalowski and Lohman,
1987). The chief assumptions are that the binding of each molecule of ligand induces
an identical spectral change in the protein and that the degree of change in the
spectral property varies linearly with the degree of saturation. Keeping in mind these
assumptions, we largely used this method in the study of the binding of various
ligands to tubulin (Barbier et al., 1995; Barbier et al., 1996; Leynadier et al., 1993;
Peyrot et al., 1992; Rappl et al., 2006).
In fluorescence, another important process that occurs in the excited state is
resonance energy transfer. This process occurs whenever the emission spectrum of
a fluorophore, called the donor, overlaps with the absorption spectrum of another
454 François Devred et al.
compound, called the acceptor (Förster, 1948). The acceptor does not need to be
fluorescent. FRET occurs without the transfer of a photon, but rather is the result of
long-range dipole–dipole interactions between the donor and acceptor. The distance
dependence of FRET has resulted in its widespread use to calculate distances
between donors and acceptors. For tubulin, intrinsic and extrinsic fluorescent probes
have been used in conjunction with FRET methodologies to measure distances
between different tubulin ligands (Bhattacharyya et al., 1993; Bhattacharya et al.,
1996; Han et al., 1998; Ward and Timasheff, 1988; Ward et al., 1994), to monitor
tubulin conformational changes (Bhattacharya et al., 1994; Prasad et al., 1986; Soto
et al., 1996), and to follow tubulin polymerization (Bonne et al., 1985; Kung and
Reed, 1989). For example, Ward et al. (1994) measured, by FRET experiments, the
spatial separation between the colchicine and Ruthenium Red binding sites, the high-
affinity bisANS and Ruthenium Red sites, and the allocolchicine and high-affinity
bisANS sites on tubulin. Recently, Makrides et al. (2004) established a probe based
on FRET that allowed measurement of the interaction between tau and microtubules.
Tau does not contain any tryptophan residue (Trp), but does contain two cysteine
residues (Cys-291 and Cys-322) that can be labeled to stoichiometry by the fluor-
ophore acrylodan. This latter fluorophore then serves as an efficient acceptor of
energy transfer from the tubulin donor tryptophan residues at the condition that the
complex is formed. It should however be noted that the Trp/acrylodan pair is not a
very efficient FRET pair, so this technique did not allow us to study the lower
affinity accumulation of tau on MT surface as we will explain later.
NMR spectroscopy (see Chapter 22 by Clément et al., this volume), although
capable of providing structural and dynamic information on a per-residue basis in
smaller systems, seems at first not ideally suited for the study of a macromolecular
assembly comprising tau and tubulin. First, the size of the tubulin dimer, with a
molecular weight of ~100 kDa, and outpassing the megadalton or higher when
assembled in rings or microtubules, invariably leads to significant line broadening.
Modern NMR techniques that exploit spin dynamics to reduce the transverse relaxa-
tion even in larger systems do crucially depend on deuteration of most of the carbons
of the protein. The absence of an effective over-expression system for tubulin
precludes this, and direct NMR analysis of tubulin therefore is currently out of
reach. Tau, on the other hand, suffers from the fact that it is natively unfolded, and
therefore shows a very limited dispersion of its amide proton resonances. Whereas
this has proven to be a barrier for NMR analysis of this protein, despite its important
physiological and pathological role, we realized that it also could be an advantage as
it implies that the carbon chemical shifts of the residues are known (Lippens et al.,
2004). Based on this a priori knowledge, we could assign about 40% of the
resonances, and very recently, Mukrasch et al. (2009) exploited the resolving
power of a 900MHz NMR spectrometer to obtain the full assignment of tau.
However, our initial assignments proved to be largely sufficient for the study of
molecular interactions (Sibille et al., 2006) and for the effect of posttranslational
modifications (Amniai et al., 2009; Landrieu et al., 2006). As for this latter aspect of
evaluating the phosphorylation status of a complex sample as a multi-phosphorylated
tau, NMR has some decisive advantages over other analytical techniques such as
mass spectrometry and/or immunochemistry. Although it requires at least
15N-labeling of the protein, and can therefore not be performed on material isolated
from brain or other tissues, NMR allows us to see all the sites that are modified in a
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single experiment, and can readily identify and quantify them. This later aspect is
important, as even the notion of “hyperphosphorylated” often used in the literature to
characterize PHF-tau has not yet been properly defined.
Here, we would like to address the feasibility of using NMR to study MAP–MT
complexes, taking into account several experimental considerations. First, tau
decreases the critical concentration for tubulin assembly into microtubules at 37°C.
At lower temperature, tau promotes the formation of rings, and therefore signifi-
cantly increases both the size and the heterogeneity of the sample. Measuring
directly at 37°C is also problematic, as the amide protons of tau exchange rapidly
with water protons, leading to broader lines when working at higher temperatures.
Second, when working directly with taxol-stabilized MTs, two limiting factors are
the inherent instability of tubulin (even with the best purification protocol, samples
are rarely stable after 24 h) and the limit imposed on the concentration as micro-
tubules tend to form a liquid crystalline phase above a critical concentration (Hitt
et al., 1990). The third consideration concerns the stoichiometry of tau on the tubulin
surface. Whereas accumulation of tau on the MT surface has been described from the
early eighties on (where it was called “the parking problem”), and can be reproduced
by the co-sedimentation experiments we described above, the stoichiometry as
determined by fluorescence (Makrides et al., 2004) seems to be one tau molecule
per two tubulin heterodimers. Taken together, these factors limit the nature of the
NMR experiments that are feasible, especially when considering the inherent poor
sensitivity of NMR. Still, we want to show in the present review that NMR experi-
ments on the isolated MAPs can be extended to their complexes with different forms,
and that these in vitro studies can complement the above-described experiments that
give further insight in the thermodynamic parameters derived.
Valuable information about the molecular mechanisms that govern the highly
dynamic yet tightly regulated MT–MAP system can be obtained by studying the
thermodynamics of complex formation between the cytoskeleton network and its
regulators. We will present in this chapter how biophysical techniques such as AUC,
ITC, FRET, NMR, and co-sedimentation can be applied to MAPs focusing on tau
and stathmin and what precautions must be taken while applying them to such a
delicate system as MT cytoskeleton, each technique having its advantages, qualities,
requirements, and limits.
III. Materials and Methods
A. Protein Purification and Sample Preparation
Tubulin extraction from lamb brain was conducted following the Weisenberg
procedure well described in microtubule protocols (Andreu, 2007). Tau and stathmin
were recombinant proteins. Human hTau40 (the largest tau isoform) and stathmin
were expressed from a pET vector introduced into Escherichia coli BL21(DE3).
Expression was induced by isopropyl 1-thio-D-galactopyranoside (IPTG) during the
bacterial exponential growth phase. Tau bacterial lysates obtained by sonication,
were heated at 90°C. After being cleared by centrifugation at 17,000 g for 20min
at 4°C, the supernatant was loaded onto a 5ml HiTrapTM SP Sepharose HP cation
exchange column (GE Healthcare) pre-equilibrated with 50mM MES (pH 6.5) and
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eluted with a buffer consisting of 50mM MES and 0.5M NaCl (pH 6.5). Fractions
containing tau protein were pooled, dialyzed overnight against 50mM ammonium
bicarbonate and dry-lyophilized. Stathmin purification was also realized without the
use of tag that might modify its structural physical and interacting properties., Since
stathmin is thermostable like tau, the preparation was boiled and then purified using
an anion exchange column 5ml HitrapTM DEAE-FF. An additional reverse phase
step (15RPC PE 7.5/150) was then used to get rid of the degraded form of stathmin
(Devred et al., 2008). Fractions containing stathmin were pooled and directly dry-
lyophilized. Purity was evaluated by SDS-PAGE and then confirmed by MALDI
mass spectrometry and peptide mass fingerprinting.
Tubulin concentration was determined spectrophotometrically at 275 nm with an
extinction coefficient of 109,000M1 cm1 in denaturizing conditions (6M guani-
dine hydrochloride). The concentration of tau, which has an extinction coefficient
7700M1 cm1 at 280 nm, was determined using its absorbance spectrum (220–
450 nm) corrected for light scattering. Since stathmin bears no aromatic residues, we
used colorimetric methods (DC Protein Assay, Biorad) with BSA as standards.
For microcalorimetry and AUC methods, it is extremely important to use identical
buffers for references and sample solutions. For ITC especially, due to the extreme
sensitivity in the signal measurement, it is extremely important that the two solutions
be matched with regard to composition, pH, buffer, and salt concentration. If the two
solutions are not perfectly matched, there may be heat of mixing (or dilution) signals
that will overwhelm the heat signals for the binding reaction. After purification,
tubulin is stored in buffer containing 1M sucrose to stabilize its conformation and is
stable for several years when stored in liquid nitrogen. Before tubulin is used the
sucrose should be removed. For most of the systems, extensive dialysis is usually
employed to exchange buffers. Nevertheless, because of tubulin fragility it is not
possible to dialyze it in absence of a stabilizer such as sucrose. Tubulin was thus
passed through a drained gel filtration Sephadex G25 resin equilibrated with appro-
priate buffer using a spin column (1 5 cm), followed by a passage through second
larger (110 cm) gravity column packed with Sephadex G25 resin equilibrated with
the same buffer (Barbier et al., 1998; Peyrot et al., 1992). Dry lyophilized tau and
stathmin were directly dissolved in the desired buffer just before use, to minimize the
possible heat of mixing in ITC. After centrifugation to remove the aggregated
proteins, the concentration was measured (see above).
To phosphorylate recombinant tau protein, tau (10 μM) was incubated with 0.1
μM recombinant PKA catalytic subunit (for the PKA phospho-Tau) or with 0.08 μM
of the recombinant cyclin-dependent kinase CDK2/CycA3 in a buffer containing
1mM ATP, 12.5mM MgCl2, 50mM HEPES (pH 8), 55mM NaCl, 5mM DTT, and
1mM EDTA for 16 h at 20°C. The reaction mixture was then buffer exchanged
against 50mM ammonium bicarbonate before lyophilization. SDS-PAGE (12%) was
used to check the integrity of the samples. Tau incubated in the kinase buffer without
kinase or without ATP was used as control in the polymerization experiments.
B. Analytical Ultracentrifugation
AUC consists of the application of a centrifugal force that induces sedimentation
of a macromolecule or a mixture of macromolecule in solution. This sedimentation is
observed by detection of the macromolecule during the centrifugation by absorbance
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or interference optics. As already mentioned the sedimentation of a macromolecule
is linked to its shape and molecular weight by the following relation:
S ¼ Mð1 vÞ
Nf
ð5Þ
With S the sedimentation coefficient in Svedberg (1013 s), M the molar mass, v the
partial specific volume, f the frictional coefficient of the macromolecule,  the
solvent density, and N the Avogadro number. Sedimentation velocity data can be
analyzed by different software available on the http://www.bbri.org/RASMB/rasmb.
html web page. Some of them, such as Sedfit program developed by P. Schuck, were
based on the analysis of the detailed sedimentation-diffusion equation, the Lamm
equation, which describes the evolution of the complete concentration profiles
during sedimentation velocity run (C(S) distribution). Other, such as DCDTþTM
program developed by J. Philo, implements the time derivative data analysis (dc/dt
methods) originally developed by W. Stafford; for details see (Scott and Schuck,
2005). We will use these two approaches to quantify the interaction between tau/
stathmin and tubulin by AUC. Partial specific volume of tau and stathmin are 0.724
and 0.7341ml/g respectively, both predicted by the software SEDNTERP (Laue
et al., 1992) and that of tubulin is 0.736ml/g (Lee and Timasheff, 1974) at 20°C. The
buffer used in all experiments was phosphate buffer 20mM, GTP 10 μM, pH 6.5 and
its density and viscosity were 1.009 g/ml and 0.001047 poise, respectively. Tubulin
needs GTP in the buffer to stabilize its conformation over the time range of
centrifugation. More generally, 0.1–1mM of GTP is employed but nucleotides
absorb in the UV protein range and the UV scans are consequently noisy within
this range of nucleotide concentration. Thus, for sedimentation velocity experiments
involving tubulin, we used minimum GTP concentration, i.e., 10 μM. Under these
conditions the nucleotide composition of tubulin was 87% GTP–tubulin, which is
not significantly different from the 90% GTP–tubulin equilibrated with 104 M GTP
(Devred et al., 2004). Various concentrations of protein or protein mixtures were run
at 40,000 rpm at 20°C in a Beckman Optima XL-A analytical ultracentrifuge
equipped with absorbance optics, using 12mm charcoal filled Epon double-sector
centerpieces and tubulin concentrations as low as 2 μM. Data were acquired in
continuous mode at 280 nm or 290 nm. For tau characterization, higher speed was
used (55,000 rpm) with a 12mm aluminum double-sector centerpiece.
C. Co-sedimentation Assay
In addition to ITC and AUC, co-sedimentation assay can be used for affinity
constant determination by assessing the amount of bound and free ligand and
receptor. In this part, we will focus on tau–tubulin interaction. Taxol-stabilized
MTs were formed by incubation of 15 μM of tubulin with 15 μM of taxol during
25min at 37°C in phosphate buffer 25mM, NaCl 25mM, pH 7 with 8mM MgCl2,
DTT 0.4mM, GTP 0.1mM. In this buffer, NaCl is used to avoid nonspecific
electrostatics interactions, DTT to maintain tau in its monomeric forms and magne-
sium is indispensable for taxol-induced MT formation. The stabilized microtubule
solutions (200 μl) were then diluted to the desired concentration (5 μM), taxol added
to maintain a tubulin/taxol molar ratio of about 1.5 and titrated with different
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concentrations of tau (from 2.5 to 20μM). The 200μl samples were deposed on a
200μl layer of 60% glycerol, diluted in the same buffer, to eliminate nonspecific
binding during the centrifugation. After 20min of centrifugation at 88,000 g at 20°C
(Beckman TL-100, rotor TL 100.2), the concentrations of tau in the pellets (bound tau)
and the supernatants (free tau) were determined by densitometry on SDS-PAGE with
tubulin concentration as standard. Pellets and corresponding supernatants should be
loaded in the same SDS-PAGE to eliminate error due to variation in coloration.
Because both free and bound tau concentrations were available, we can use a Scatch-
ard representation to determine the affinity constant and the stoichiometry of the
reaction. The Scatchard equation is given by B/[F]= nKa–BKa where B is the ratio
of the concentration of bound ligand (here tau in the pellet) to total available binding
sites (total tubulin concentration), [F] is the concentration of free ligand, n is the
number of binding sites, and Ka the affinity constant of tau for the microtubule.
Plotting this data, B/[F] versus B, yields the Scatchard plot with a slope –Ka and an
x-intercept of n.
This approach was also used to find the nature of the ligand-induced macromo-
lecular self-association in the case of tau-induced tubulin self-association into micro-
tubules. In that case, Scatchard plots are usually curved downward reflecting the fact
that ligand-induced tubulin assembly may proceed by two different pathways
(Devred et al., 2004): either a ligand-facilitated elongation pathway, in which the
elongation precedes the binding of the ligand (Eq. 6) or a ligand-mediated elongation
pathway, in which the binding of tau, to either tubulin or microtubule, precedes the
elongation (Eqs. 7 and 8).
MTþ Tub !K2 MT Tubþ tau !K1 MT Tub tau ð6Þ
tauþ Tub !K1 Tub tauþMT !K2 MT Tub tau ð7Þ
MTþ tau !K1 MT tauþ Tub !K2 MT Tub tau ð8Þ
Equation (6) is characterized by an apparent elongation constant Kapp=K2(1þ
K1[tau]). Equations (7) and (8) are not thermodynamically discernible and are
characterized by an apparent elongation constant Kapp=K1K2[tau]/(1þK1[tau])
(for more details, see the appendix of Buey et al., 2004). The equation best fitting
the data, using a graphics fitting program (Sigmaplot 4.0, Jandel Scientific), will
favor one or the other model.
D. Fluorescence or Förster Energy Transfer (FRET)
FRET was extensively employed to measure distance between different reactive
sites in a protein, proteins in lipids or in cell surface. With recent advances in
fluorescence microscopy, it has also been used to study direct protein–protein
interaction in living cells and in solution. While the fluorescence methods seem
quite simple and sensitive, special care must be taken to study the interaction
between two proteins (Garnier et al., 1998). Indeed, fluorescence requires proper
spectral corrections for a number of possible artifacts: light scattering, inner filter
effects, and temperature dependence of fluorescence quantum yields. These
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problems are particularly important in the determination of the maximal spectral
perturbation needed to establish the extent of binding. In FRET, a donor molecule
with a fluorophore absorbs light at a certain wavelength to be in a higher electro-
nic energetic state. Then, the acceptor in the proper orientation and distance
receives a nonradiative transfer of energy from this donor, resulting from a
dipole–induced dipole interaction. If the acceptor molecule is fluorescent, it is
then excited to a higher electronic energetic state and electrons decay back down
emitting fluorescence photon at larger wavelength (stoke shift). There are three
conditions necessary for efficient energy transfer: the donor emission spectrum
must overlap the acceptor absorbance spectrum, the donor and acceptor fluoro-
phores must be sufficiently aligned so that an acceptor dipole can be induced by
the donor, and the donor must not be separated from the acceptor by a distance
greater than ~60 Å.
For tau–tubulin interaction we used acrylodan (6-acryloyl-
2-dimethylaminonaphthalene)-labeled tau to study the tau–tubulin interaction, with
the fluorophore covalently attached to Cys-291 and Cys-322 (Makrides et al., 2004).
To label the protein, tau was first extensively reduced with a 10-fold molar excess of
DTT for 2 h, desalted on a 5ml column of sephadex G-25 to remove the excess of
DTT and then incubated 2 h in a dark room with a 10-fold molar excess of the thiol
reactive acrylodan. Unincorporated acrylodan was removed by a size exclusion
chromatography Sephadex G25. To avoid problems in protein concentration deter-
mination that could arise from the absorption of the residual fluorophore,
15N-labeled tau was used for this fluorophore labeling, allowing accurate determina-
tion of its concentration by comparison of its signal intensity in a 1D 1H-15N HSQC
spectrum with that of a reference spectrum obtained from a 15N-labeled sample
before acrylodan labeling. 1 μM of MTs solution was mixed with various tau–
acrylodan concentrations. Fluorescence spectra are recorded from 460 to 540 nm
with an excitation wavelength of 290 nm. Similar measurements were also done
without microtubules. Fluorescence signal caused by FRET was taken as the differ-
ence between the fluorescence intensity emitted from labeled-tau in the presence
versus the absence of microtubules, at the emission wavelength giving the maximum
fluorescence. This fluorescence corrected signal was plotted versus total tau-labeled
concentration and fitted with the following equation:
F ¼ Fmax ðb
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
b2  4ac
p
Þ=2aþ y ð9Þ
where F is the experimental fluorescence emission intensity at 490 nm; c
the acrylodan–tau concentration, Fmax the fluorescence at saturating tau levels, a is
the concentration of tau binding sites, b= aþ cþKd, and y is the y-intercept value.
The maximal stoichiometry of binding, n, was derived from a= n tubulin
concentration.
E. Microcalorimetry (ITC)
Almost any chemical reaction or physical change is accompanied by a heat change.
ITC is a thermodynamic technique that allows the study of interactions between
molecules by measuring the heat released or absorbed by interacting molecules.
Since heat exchange upon binding occurs naturally, ITC does not require
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immobilization and/or modification of the reactants. Thermodynamic characteristics
such as binding constants (~103108 M1) and reaction stoichiometry can be deter-
mined from the measurements. Given improvements in ITC instrumentation and data
analysis software, it is now routinely used to directly characterize the thermodynamics
of binding interactions in many systems (Freire et al., 1990). Heat measurements can
be made in different ways, such as temperature change (adiabatic) or power compen-
sation (isothermal) principles; see review (Freyer and Lewis, 2008). Here we used ITC
to directly measure the heat of reaction, i.e., the enthalpy variation of the reaction DH.
The reaction takes place in a compartment in which ligand is injected using a syringe.
In that system, the temperature of the calorimeter measurement cell is maintained
constant (isothermal), by means of a temperature controller. As a chemical reaction
takes place in the cell, any heat change is sensed and the appropriate electric power is
applied to the controller so that again the temperature remains constant. The heating
power from the two sources, reaction and controller, are kept at a constant level so that
a heat input from the reaction is compensated by a drop in the heat input from the
controlled heater. The raw signal in the power compensation calorimeter is the power
(mcal/s or mJ/s) applied to the controller that is required to keep the calorimeter cell
from changing temperature as a function of time. A measure of the heat given to or
taken from the buffer, for exothermic or endothermic processes respectively, is
proportional to the number of moles that reacted and to the enthalpy change for the
reaction, DH (kcal/mol or kJ/mol). The heat change is then simply calculated by
integrating the heater power over the time (s) required for the controller power to
return to a baseline value.
The thermogram generated in the ITC experiment is a simple summation of all of
the heat-producing reactions that occur as an aliquot of titrant is added. In the case of
one or several identical binding site, the initial heat peaks are larger than the heat
peaks for subsequent additions, since at the beginning of the titration there is a large
excess of empty or unpopulated binding sites. Initial heat peaks most typically are
the result of complete reaction of the added ligand. As the titration proceeds, less and
less of the added ligand is bound and there are three species existing in solution: free
ligand, free protein binding sites, and the ligand–protein complex. The heat produced
in the ITC experiment is linearly dependent on the DH of the reaction and non-
linearly dependent on the K. The goal is to model the experimental data within
expected experimental error, using the simplest model, in light of what is already
known about the system (e.g., stoichiometry).
In our hands, tubulin concentration was set in the 5–20 μM range in the cell
whereas stathmin or tau was in the 15–50 μM range. Practically, in the case of a
microcalorimetry system with ITC unit (MCS-ITC), which can theoretically operate
between 0 and 80°C, 2.5ml of tubulin sample need to be prepared to fill the 1.4ml
cell, and a minimum of 750 μl of ligand (tau or stathmin) to fill the injection syringe.
The next generation model VP ITC, though more sensitive and with Peltier-
controlled rapid temperature equilibration, had about the same volume requirements.
The newest model of Microcal, iTC200, has drastically improved the two limiting
factors: time and quantities. With this new apparatus, experiments require 300 μl to
fill the sample cell and 70 μl to fill the injection syringe. With fast equilibration
times, up to two runs per hour can be easily accomplished. Furthermore iTC200 will
soon be upgraded to a fully automated version with a sample throughput of at least
50 samples per day.
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Despite of all the precautions taken to match buffer in the syringe and in the cell (see
above) there might still be some heat due to the dilution of the ligand itself and even
sometimes of the tubulin in the cell. To take these factors into considerations two
controls are to be performed. In a first one, the ligand solution is titrated into buffer in
the sample cell. In a second one, the heat of dilution of tubulin will also be measured
by simply injecting buffer from the syringe into the tubulin solution in the sample cell.
Usually the heat of dilution of the macromolecule measured in this way is negligible.
Furthermore, since the generation of bubbles in the sample solutions during an ITC
experiment will disturb the detection of the heat exchange due to the binding, the
solutions should be degassed prior to filling the cell and injection syringe.
Another calorimetric reaction that might occur in parallel of the measured binding
is the exchange of protons between the interacting molecules and the buffer, as
binding occurs. Indeed, to facilitate binding, residues at the interface may be proto-
nated or deprotonated, resulting in exchange of protons with the buffer. Calorimetry
measures the totality of heat effects in any process, and therefore detects protonation
changes involved in ligand binding as well. Although the enthalpic contributions of
protein conformational changes can be taken as an integral component of the overall
binding process, the enthalpy contribution due to protonation–deprotonation of the
buffer species must be subtracted from the enthalpy change observed to obtain the
binding enthalpy of the complex formed. To overcome this problem and therefore
obtain the true enthalpy of interaction, ITC titrations have to be performed in buffers
with significant differences in heat of ionization. For example experiments can be
performed successively in Tris–HCl (47.4 kJ/mol) and Hepes (20.5 kJ/mol). The
analysis of the dependence of the experimental DH observed in the various buffers
(DHobs) will provide the number of proton exchanged during the binding process and
the true enthalpy of binding. Another option is, when possible, to perform experi-
ments in buffers with a small heat of ionization such as phosphate buffer
(~5.0 kJ/mol).
F. NMR Spectroscopy Involving Tubulin
As NMR experiments on a protein of the size of tubulin absolutely require
deuteration to limit relaxation, the present impossibility of recombinant production
of tubulin make direct NMR observation of anything except the most flexible
polyglutamate tails nearly impossible. The purification protocols from animal tissue,
although well optimized and leading to substantial amounts of material, come with a
limited stability of the purified protein, thus limiting the applicability of the insensi-
tive NMR technique. Finally, when working with microtubules, the concentration of
the solution is equally restricted, as MTs tend to form an ordered phase in solution
above a critical concentration of 38 μM (Hitt et al., 1990). Adding to this is the
possible accumulation of tau on the MT surface, making it necessary to work at
substoichiometry ratios to probe the true tau:MT binding. Thus, the window of
experimental conditions in which to probe the tau:MT interaction by NMR spectro-
scopy becomes rather narrow. The binding partners of tubulin, be it tau or stathmin,
can however be recombinantly produced, and hence labeled with the required stable
isotopes. In our first attempts, we used 15N-labeled tau and a 1:4 ratio of tau:tubulin
dimer to avoid the previously mentioned stacking problem. NMR spectra were
acquired overnight on a 600MHz spectrometer equipped with a cryogenic probe
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head, which proved sufficient to detect those parts of tau not implicated in the binding
at the MT surface. It should be stressed that the experiment with only 5 μM of tau
succeeded because of the narrow line width of tau due to its natively unfolded
character. For a folded protein of similar size, we would not expect to obtain a
reasonable spectrum without extensive deuteration and transverse relaxation opti-
mized spectroscopy (TROSY) (Pervushin et al., 1997) at the highest fields available.
IV. Discussion
Three different issues can be addressed by our techniques. First, detecting MAP
binding to tubulin and characterizing the complexes formed; this part will be
restricted to the use of AUC to characterize tau-induced rings and stathmin-induced
T2S complex formation (this is detailed in Chapter 15 by Correia, this volume).
Second, we will focus on determining the thermodynamic parameters of the binding
of the MAP to tubulin or MT. This part will address the use of a co-sedimentation
assay with taxol-stabilized MT, FRET to characterize tau binding to MTs, and the
use of ITC to characterize stathmin binding to tubulin in absence and in presence of
antimitotic drugs. Third, we will present how NMR can help us to identify which
amino acids of tau are implicated in its binding to MTs. This will also be used in the
study of the role of specific phosphorylation of tau.
A. Evidences of MAP–Tubulin and Microtubules Complexes Formation
As already mentioned, AUC has been extensively used to study the oligomeric
state of tubulin induced by small molecules such as magnesium or the vinca
alkaloids family and provides an accurate tool for the study of MAP–tubulin
interaction. In this part, we will discuss how to study a protein–protein interac-
tion by sedimentation velocity taking the tau–MT and stathmin–tubulin interac-
tions as examples. In order to study the interaction of two proteins by
sedimentation velocity, it is first necessary to determine the sedimentation coeffi-
cient of each partner independently in the experimental conditions. Figure 1A
represents the sedimentation distribution C(S) at two tubulin concentrations. This
distribution shows one peak centered at an apparent sedimentation coefficient of
5.59 ± 0.08 and 5.54 ± 0.07 S for 0.9 and 1.2mg/ml of tubulin respectively, con-
firming its monodisperse state. Since the experimentally observed sedimentation
coefficient vary with temperature and solution density, we converted it into a
standard state of 20°C in water (S20,W) using SEDNTERP program (Laue et al.,
1992). We then plotted the S20,W versus various concentrations of tubulin to
determine the standard sedimentation coefficient at 20°C in water at infinite
dilution (inset of Fig. 1A) which is 5.97 ± 0.05 S. The frictional coefficient ratio
(f/f0), parameter reflecting the form of the molecule, could be calculated as
f/f0= Smax/S ratio where f0 and Smax are the frictional and sedimentation coeffi-
cients of a smooth unhydrated sphere corresponding to the given protein mass, S
is the experimental sedimentation coefficient obtained by AUC, and f is the
frictional coefficient of the protein (Philo, 2000). The Smax was calculated by
Sedfit and was 7.49 S giving a f/f0= 7.49/5.97= 1.25. A similar approach was
used for the second partner, i.e., tau. Tau is a natively unfolded protein of
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45,850Da. Like tubulin, tau sedimentation is monodisperse (Fig. 1B) and the
standard sedimentation coefficient of 20°C in water at infinite dilution (inset of
Fig. 1B) is 2.5 ± 0.1 S. For tau, we calculated by Sedfit the theoretical sedimenta-
tion coefficient of a smooth anhydrate sphere corresponding to 45,850Da, Smax
that is 4.5 S and obtained a frictional coefficient ratio f/f0 of 1.8 corresponding to
a much-extended protein. We have characterized the two partners of the interac-
tion, showing that both of them are monodisperse and have relatively different
sedimentation coefficients. These two conditions are favorable to study their
interaction analyzing the sedimentation profile of various mixture of the two
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Fig. 1 (A) Sedimentation distribution of tubulin obtained by Sedfit program (1.2 mg/ml dark line and
0.9 mg/ml dashed line) at 20°C. Inset: determination of the standard sedimentation coefficient of 20°C in
water at infinite dilution of tubulin. (B) Sedimentation distribution of tau obtained by Sedfit program
(1.5 mg/ml dark line and 0.8 mg/ml dashed line) at 20°C. Inset: determination of the standard
sedimentation coefficient of 20°C in water at infinite dilution of tau.
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proteins monitored at 280 nm, or 290 nm for concentrated tubulin samples, keep-
ing in mind that the sedimentation are not additive. Because tubulin is a protein
containing eight tryptophane residues with an extinction coefficient at 280 nm of
116,000M1 cm1 and tau, a protein containing only tyrosine with a 15-fold
lower extinction coefficient ("280 nm= 7700M
1 cm1), the absorbance signal
contribution of tau could be neglected. Note that the difference in their extinction
coefficient is more pronounced at 290 nm. It is important at this stage to discuss
the choice of the data analysis. We know from the previous experiments with
protein alone that tubulin and tau have very different frictional coefficient ratio. C
(S) distribution assumes that all species present in the solution have a uniform
frictional ratio, which is not clearly the case for tubulin and tau. Thus, we
analyzed the data using the apparent sedimentation coefficient distribution g(s*)
generated by DCDTþ program (Philo, 2000; Stafford, 1992). As expected for
monodisperse species, tubulin and tau sedimentation profiles analyzed by
DCDTþ are similar to that obtained by Sedfit. Figure 2A shows the single
Gaussian distribution of g(s*) of 16 μM tau and 15 μM tubulin obtained in
separate experiments. As with Sedfit, the tubulin peak was centered on
5.43 ± 0.03 S and the tau peak on 2.29 ± 0.08 S. Tubulin at fixed concentration
was mixed with various concentrations of tau. The distributions g(s*) were then
fitted with Gaussian curves, and the areas and maximum, which represent the
sediment coefficient of the sample, were calculated. We used this analysis to
qualitatively characterize the tau–tubulin interaction, keeping in mind that the
boundaries do not represent individual species but interacting zones. Figure 2B
shows a trimodal pattern resulting from the interaction of 15 μM tubulin and
7.5 μM tau. The g(s*) distribution, which is very sensitive to the presence of
multiple species, was fitted with three Gaussian curves centered on 6S, 30–35S,
and 40–50S, respectively. To test the nature of the equilibrium, similar experi-
ments were performed at a 30,000 rpm. They led to the same sedimentation
pattern, indicating that this self-associating system was in rapid equilibrium
(Lee and Rajendran, 1994). Amount of the different sediment boundaries (inset
of Fig. 2B) were calculated by integrating the Gaussian curves obtained for the
different peaks for different tau/tubulin molar ratios and different tubulin con-
centrations and the results obtained indicated that the formation of these different
species is an equilibrium system dependent on tubulin and tau concentration. To
visualize the structure of the polymers formed, we used transmission electron
microscopy. Complexes evidenced by AUC consisted of circular polymers that
were mostly single wall rings with an average external diameter of about
45 ± 5 nm and an internal diameter of 30 ± 5 nm, corresponding to about 14
tubulin dimer rings and the presence of other circular polymers, such as thick
wall rings and possibly spirals, as well as partial rings (Devred et al., 2004). This
structural heterogeneity could explain the wide profile of peaks in the g(s*)
distribution of the fast sedimenting species in the sedimentation velocity experi-
ment (Fig. 2B). Because of the numerous structures of tubulin oligomers in the
presence of tau, only qualitative data could be obtained by AUC. However, this
method is an immediate method to check tau binding and functionality (Amniai
et al., 2009). For example, we used it to study the effect of posttranslational
modification of tau known to regulate its interaction with tubulin. By reporting
the amount of the slower sedimenting peak as a function of tau/tubulin ratio we
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followed the effect of tau phosphorylation by the activated CDK2/cylcine A3
kinase complex (inset of Fig. 2B). In this condition, tau is phosphorylated on
serine 202/threonine 205 and threonine 231/serine 235, which corresponds to the
well-known Alzheimer epitopes AT8 and AT180, respectively. AUC clearly
shows that within the same concentration range, phosphorylated tau is not able
to form rings from tubulin dimers (dotted line).
S*
S*
0 42 86 12 1410
g (
S*
 )
0.0
0.1
0.2
0.3
0.4
0.5
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70
g (
s*
 )
0.000
0.025
0.050
0.075
0.100
(A)
(B)
[Tau]/[tubulin] 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6
%
 o
f s
lo
w 
bo
un
da
ry
 
0
20
40
60
80
100
Fig. 2 Sedimentation velocity of tau tubulin interaction at 20°C. (A) Apparent sedimentation
coefficient g(s*) distribution of tau protein (16 μM) alone (open circle) and tubulin dimers (15 μM)
alone (open square) computed from the time derivative of the concentration profile by the method of
Stafford (dark lines). (B) Apparent sedimentation coefficient g(s*) distribution of 15 μM tubulin mixed
with 7.5 μM of tau. This distribution was analyzed by DCDT software, with three Gaussian curves
representing three sedimentation boundaries respectively in the plane line, dotted line, and dashed line.
Open circles represent experimental values. The long dashed dotted line represents the best fit curve. The
inset shows the percentage of the slower boundaries (10 μM) tubulin in function of the tau/tubulin molar
ratio for unphosphorylated (dark line); and phosphorylated tau (dotted line).
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Another complex that can be easily analyzed by sedimentation velocity is the
tubulin–stathmin complex (T2S). Tubulin sediments with an apparent sediment
coefficient of 5.08 S whereas T2S, formed by two tubulin molecules linked by
the helix of stathmin, sediments with a sediment coefficient of 7.7 S. Because
stathmin has no aromatic residues, the absorbance measured in sedimentation
run in the XLA was directly proportional to the tubulin concentration. As shown
in Fig. 3, data analyzed by DCDTþ (A) or sedfit (B) gives similar results. In
this case, AUC can be used to monitor the effect of other molecules like
antimitotic drugs on the T2S formation. For example, we used it in complement
with isothermal titration microcalorimetry, to monitor the oligomeric state of
tubulin in presence of vinblastine, showing that stathmin induced the depoly-
merization of vinblastine oligomers to from T2S-like complexes. The thermo-
dynamic parameters of this interaction were subsequently determined by ITC
(Devred et al., 2008).
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Fig. 3 Sedimentation velocity of tubulin alone (7 μM) (dark line) and with 4 μM of stathmin at 20°C
analyzed by DCDTþ (A) or by Sedfit (B).
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B. Thermodynamic Parameters Determination of MAP–Tubulin Interaction
Having shown that stathmin bound to tubulin to form T2S complexes even in
presence of vinblastine, we decided to study the thermodynamic parameters of its
binding to tubulin as described previously (Honnappa et al., 2003). If at a given
temperature DH is too small to be measured, one needs to change the temperature to
obtain a greater signal. This is the case for stathmin–tubulin interaction for which DH
is close to null at 25°C. Having the choice of increasing the temperature or decreas-
ing it, we chose to decrease it to 10°C, a temperature much more compatible with the
long study of tubulin. Black curve in Fig. 4 shows the typical endothermic profile of
a stathmin to tubulin binding at 10°C. On the upper panel each peak corresponds to
the injection of 10 μl of stathmin at 76 μM into a tubulin dimer solution at 10 μM.
The reaction heat measured for each injection, decreases as less and less tubulin is
available for stathmin binding. After 15 injections, no further heat change is detected
but the one due to stathmin dilution, which indicates that all stathmin is bound to
tubulin. The lower panel shows the integrated heat peaks of reaction as a function of
the stathmin/tubulin molar ratio. This representation of the abscissas enables us to
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Fig. 4 Typical ITC curves of stathmin interaction with tubulin. Upper panel shows the raw data
obtained for 25–30 injections, each of 10 μl, of stathmin (76 μM) into the sample cell containing tubulin
(10 μM). The two titration curves were obtained during one set of experiments; the upper curve (black,
which was translated upward for clarity purposes) corresponds to binding in absence of vinblastine,
whereas the lower one (gray) corresponds to the binding in presence of vinblastine. Lower panel shows
the integrated heats of reaction (symbols) in absence (black circles) and in presence of vinblastine (gray
squares) with the best fit to the data (line). The measurements were carried out at 10°C in 20 mM NaPi,
GTP 0.1 mM pH 6.5.
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take into consideration the slight but not negligible change of tubulin concentration
upon injection. Experiments carried out in phosphate buffer are minimally affected
by a possible proton exchange and therefore the heat measured is solely due to the
interaction. To analyze our stathmin–tubulin binding data we used the simplest
model compatible with our raw data, based on previous studies reporting that
stathmin binds two tubulin subunits with equal affinities under all conditions inves-
tigated by ITC (Honnappa et al., 2003; Honnappa et al., 2006). The analysis of the
binding isotherm in their work and in ours is based on the model that assumes n
independent and equal binding sites on stathmin for tubulin.
We then conducted the same experiment in presence of vinblastine, a drug known
to trigger the formation of indefinite tubulin spiral polymers. Nevertheless, having
shown that addition of stathmin leads to the same T2S-like complex and that no
interfering signal from tubulin assembly or disassembly was observed, we analyzed
our data with the same model. In our conditions, we could not take into account the
linkage between drug binding and ligand-induced binding oligomer formation,
nevertheless it enabled us to compare stathmin binding on free tubulin and on tubulin
spiral oligomers.
In the presence of vinblastine, we encountered another issue when measuring
stathmin binding to tubulin. Indeed, one of the limitations of ITC is the range of
binding constants that can be determined directly. If C is the concentration of the
macromolecule in the calorimeter cell and Kd is the dissociation constant measurable
with accuracy, C should be in the range Kd/100 £C£Kd 100. Commonly used
tubulin concentrations are between 20 μM and 1 μM for ITC which limits the range
of measurable binding constants to 500M1108 M1. When the association con-
stant Ka exceeds 10
8 M1, the steepness of the isotherm does not allow accurate
estimation of the binding constant. This is what happened in our study of stathmin
binding to tubulin in the presence of vinblastine (see Fig. 4 bottom gray lines in the
upper panel), which gives an underestimated binding constant that falls outside of
the confidence interval of the apparatus. In that case, we used another thermody-
namic path described in our study to calculate the more accurate binding constant
(Devred et al., 2008). But in some cases, when there is only one path possible, and
the protein concentration in the cell cannot be lowered without loss of signal, we
have to use another method to counter this problem. For example, competition or
displacement titration calorimetry (Berland et al., 1995; Sigurskjold, 2000) measures
an apparent binding constant (Kapp) corresponding to the displacement of a low-
affinity ligand by a stronger one.
Such an approach was applied by our team to the measurement of coumarin
binding to a bacterial protein DNA gyrase (Lafitte et al., 2002), and could have
been used in the case of stathmin–tubulin binding in presence of vinblastine if no
other thermodynamical path was available. It would have implied the existence of
another MAP or mutant of lower affinity for tubulin by site directed mutagenesis. Let
us consider the use of a stathmin mutant (L1) with a lower binding affinity for tubulin
than stathmin (L2) in presence of vinblastine. The fairly simple protocol is first to
obtain the binding parameters of L1 using the standard procedure as previously
described. Then the tubulin–VLB would be saturated with the low-affinity ligand
L1 introduced into the calorimeter cell and then titrated with aliquots of high-affinity
ligand L2. The titration curve would be fitted to give an apparent binding constant,
corresponding to the displacement of L1 by L2. Then, knowing the binding constant
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K1 of L1, we could have estimated the value of the binding constant K2 of normal
stathmin for tubulin from the equation K2=Kapp(1þK1[L1]). This analysis derives
from the rigorous analysis of Sigurskjold et al. which applied least-squares nonlinear
regression method for the characterization of such displacement titration (Sigursk-
jold, 2000). Using this method binding constants up to 1013 M1 have been
measured.
As we mentioned earlier it is often useful to carry out the binding measurement at
different temperature to obtain the change in heat capacity of the binding (DCp). As
we have already mentioned, heat capacity corresponds to the increase in energy with
temperature: Cp =dH/dT, but it can also be defined as the temperature dependence of
the entropy Cp= T dS/dT. Therefore, change in heat capacity upon binding (DCp) is
calculated using the following equations: DCp= dDH/dT or DCp= T dDS/dT. This
change in the heat capacity of binding (DCp) is related to solvatation changes
between two states of a system and can be determined by ITC measurements
performed over a range of temperatures. This parameter is important for under-
standing how a protein adapts to the incorporation of the ligand. Upon binding,
conformational changes can expose or hide apolar surfaces, resulting in a positive
(exposure) or negative (hiding) contribution to DCp (Jelesarov and Bosshard, 1999).
In addition, the ligand binding decreases the protein surface accessibility to the
solvent and hides apolar surfaces that are responsible for the major positive con-
tribution to DCp (Jelesarov and Bosshard, 1999).
ITC measurements have to be carried out at least at four temperatures on the
wider temperature range possible (usually between 10 and 40°C) to avoid protein
denaturation. It could be useful to perform a differential scanning calorimetry (DSC)
run prior to a DCp measurements to determine the starting temperature for protein
unfolding. For tubulin, Diaz et al. (1993) performed DSC experiments in PEDTA
buffer pH 6.7 in various conditions of magnesium and GTP/GDP concentrations.
No denaturation was observed below 40°C. Therefore, it could be reasonable to
choose 35°C as the highest temperature for performing the ITC measurements. The
DH of binding is then plotted against temperature, and the data is fitted to a linear
function to obtain the DCp of binding. Interpretation of the biological significance of
DCp relies on physical but also empirical rules (Prabhu and Sharp, 2005). First, the
sign of DCp distinguishes apolar (þ) from polar (–) solvation (Privalov and Gill,
1988), a positive DCp, rather than negative DS, is now considered the signature of
the hydrophobic effect. Second, solvation of polar groups found in proteins is
characterized by both negative DCp and DS at room temperature (Murphy et al.,
1990). Third, globular protein unfolding usually has a positive DCp. This type of
analysis has been applied to ligand binding to tubulin by Das et al. (2009) who have
shown that that the enthalpy of association of indanocine with tubulin is negative
and occurs with a negative heat capacity change (DCp= –175.1 cal mol1 K1). It
has also been applied to stathmin binding to tubulin to form a T2S complex
(Honnappa et al., 2003). The tubulin–stathmin binding reaction was monitored as
a function of temperature. The reaction enthalpy was found to be endothermic at
low temperatures and decreased linearly with temperature. Extrapolation to higher
temperatures predicts DH= 0 kcal/mol at 28°C and exothermic above this tempera-
ture. Hence, below 28°C the interaction between tubulin and stathmin is completely
entropy driven, above this temperature both enthalpy and entropy contribute favor-
ably to the binding reaction. The resulting molar heat capacity change of the
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binding reaction is largely negative (DCp= –860 cal mol1 K1), which is indica-
tive of a hydrophobic reaction (removal of nonpolar surface from water) along with
T2S complex formation.
In addition, in a recent paper we showed that the DCp values of vinblastine binding
in absence or presence of stathmin are also negative: –388 ± 32 cal mol1 K1 for
vinblastine binding to tubulin and –1052 ± 56 cal mol1 K1 for VLB binding to T2S
(Devred et al., 2008). Since the VLB site on tubulin is the same in T2S as in VLB-
induced oligomers (Gigant et al., 2005), this difference in the DCp observed in the
two binding processes depends on the presence of stathmin, and can be explained by
the positive contribution to DCp from the burying of inter-tubulin interface hydro-
phobic surfaces during VLB-induced tubulin oligomerization (Makarov et al., 2007).
Moreover, these values of DCp enabled us to calculate DH= 2 kcal/mol for VLB
binding to tubulin and DH= –20 kcal/mol for VLB binding to T2S at 37°C. These
results indicate that at the physiological temperature stathmin changes the thermo-
dynamic mode of VLB binding to tubulin to an enthalpy-driven one, thus contribut-
ing to the observed increase in affinity of VLB to tubulin.
Since tau induces polymers even in “non-polymerization conditions” as demon-
strated by AUC (Devred et al., 2004), we performed co-sedimentation assay rather
than ITC to characterize tau binding to tubulin. Using this approach with non-
stabilized microtubules, we demonstrated that tau-induced tubulin assembly was
following a ligand-induced mechanism rather than a ligand-stabilized mechanism.
Then, in order to measure tau-binding parameters to tubulin, we used taxol-stablized
MTs. In both cases we used the different sedimentation properties between free tau (a
45 kDa protein) and MTs-bound tau in a co-sedimentation assay. Preformed taxol-
stabilized MTs were titrated with various tau concentrations at 20°C. By centrifuging
samples through a glycerol cushion to eliminate unspecific binding, supernatants and
pellet were separated and analyzed by SDS-PAGE to determine the fraction of bound
and free tau. B (bound tau concentration divided by total tubulin concentration) was
divided by free tau concentration F and plotted versus B in a Scatchard plot
representation (Fig. 5). Data analysis by linear regression gives a slope correspond-
ing to an association constant Ka= 7.8 ± 0.2 105 M1 with 2.8 ± 0.3 identical
binding sites. Fitting the same data plotted as a saturation curve (inset of Fig. 5)
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Fig. 5 Scatchard analysis of the co-sedimentation assay with 5 μM of MTs solution mixed with various
tau concentrations. Inset: similar data analysed by saturation analysis.
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leads to a dissociation constant of 1.1 ± 0.3 μM which corresponds to a similar value
of association constant (9.4 105 M1).
This method is limited by the SDS-PAGE sensitivity, which is too low for tau
concentration below 2μM. In the range of concentration covered by SDS-PAGE, we
cannot determine association constants greater than 107 M1. The stoichiometry
close to three moles of tau for one mole of tubulin obtained by co-sedimentation
suggests the presence of a tau accumulation on the MT wall. This accumulation
could be suppressed when we performed co-sedimentation assays in the absence of
DTT. Under these conditions, an intramolecular sulfide bridge is formed that blocks
tau accumulation on MT because the stoichiometry decreases to one with a slight
decrease of affinity constant (Sillen et al., 2007). In order to measure the binding of
the first tau to the microtubule wall, as opposed to the two subsequent events, we
used FRET with tau cysteines labeled with acrylodan as previously described
(Makrides et al., 2004). We exploited the energy transfer between tryptophan/
tyrosine residues of tubulin as donors and the fluorophore acrylodan on tau as
acceptor. Since the tubulin–tau distance is comparable to the Förster distance, i.e.,
typically in the range of 20–60Å, FRET provides a powerful and complementary
tool to quantify the interaction between microtubule and tau. Titration of a fixed
concentration of MTs (1 μM) with various concentration of acrylodan-labeled tau
gave a values of Kd= 20 ± 4 nM and a stoichiometry n= 0.40 ± 0.04 of tau binding
sites per tubulin dimer, in good agreement with literature (Makrides et al., 2004).
The discrepancy with the co-sedimentation results therefore suggests that FRET only
accounts for the direct tau/MT interaction, whereas the co-sedimentation assay
detects all bound tau protein, including the molecules that interact far away from
tubulin aromatic residues, possibly via a tau–tau interaction (Sillen et al., 2007).
FRET is thus appropriate to study the effect of the most important posttranslational
modification, the phosphorylation, on the direct tau–MT interaction. When tau is
phosphorylated on the serine 214 by PKA in vitro, its binding is reduced 100-fold
(Sillen et al., 2007). By contrast, tau phosphorylation on Alzheimer epitope AT8 and
AT180, does not modify its affinity (Amniai et al., 2009). It is well known that tau
binding on MTs is related to its induction and stabilization of MTs functions.
Nevertheless, in recent studies (Amniai et al., 2009), AUC and FRET enabled us
to demonstrated that tau phosphorylated at epitope AT8 and AT180 lost its ability to
induced MTs and ring formation even though its affinity for MTs remained
unchanged. These results were confirmed by the use of tau mutants where only
one epitope is maintain by replacement of the serine and threonine of the other
epitope by alanines. We found that the presence of only one epitope (AT8 or AT180)
is not sufficient to divert tau from its function.
C. Detailing the MAP–MT Interface: NMR
Whereas the above-mentioned methods can demonstrate the formation of a com-
plex, determine its size, shape and stoechiometry, and can eventually yield numerical
values for the thermodynamic parameters that characterize the complex, mechanistic
details at the atomic level are general missing. The method of choice to provide such
details is X-ray crystallography, as beautifully exemplified by the high-resolution
structures of the RB3 SLD complexed to two tubulin dimers (Gigant et al., 2000;
Gigant et al., 2005; Ravelli et al., 2004). These structures allow the observation of
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the RB3 helix with high resolution and detail all the intervening interactions (with a
view on the individual hydrogen bonds, aromatic stacking interactions, etc.). Unfor-
tunately, crystal structures of tau bound to the tubulin surface are currently lacking,
despite intense efforts of several groups. Structures at the atomic level of tau in its
complex with whatever form of tubulin are therefore still missing. As a consequence,
we lack a deeper understanding on how tau stabilizes the microtubule, and how
phosphorylation regulates this functional aspect. High-resolution metal-shadowing
and cryo-electron microscopy showed that tau binds mainly to the outside of the
microtubules (Santarella et al., 2004), but did not give any detailed insight in the
molecular interactions that underlie the association.
NMR of the MAPs and their complexes with microtubules has only very recently
been reported. Despite some early work describing the observation of NMR signals
from the flexible polyglutamate tails of tubulin (Reed et al., 1992), MAPs such as tau
were thought to be inaccessible for NMR studies due to their size and natively
unfolded structure, rendering a sequence specific assignment impossible. We, how-
ever, realized that accepting this natively unfolded structure implied that at least the
carbon chemical shifts were known. Tracing back the amide correlations from these
carbon Ca and Cb chemical shifts, we obtained first a partial assignment of full-
length tau (Lippens et al., 2004), that we then completed by a strategy dubbed
“peptide mapping by NMR.” In the latter approach, we superposed the 1H,15N
spectra of small tau peptides recorded at natural abundance with the spectrum of
full-length tau. Good overlap allowed us to complete the assignment, and equally
provided a definition of the natively unfolded structure of tau (Smet et al., 2004).
Further improvements came by the use of higher field and lower temperature. As an
example, we show the spectra of the same fragment of tau at 800MHz and 4°C
versus at 600MHz and 20°C, where one can easily see the spectral improvement
produced by increasing the field strength and lowering the temperature (Fig. 6).
Taking into account the experimental considerations mentioned above, in our
studies of complexes between tau and taxol-stabilized microtubules, we measured
a single 1H, 15N HSQC on a 5 μM 15N-labeled tau sample in its complex with 20 μM
tubulin assembled into taxol-stabilized MTs. From the disappearance of resonances
in the overnight spectrum, we concluded that the region of direct physical interaction
between tau and the MT surface spans the tau fragment from Ser214 to Thr377
(Sillen et al., 2007). Although we did observe zones of intermediate intensity
between the invisible interface and the flexible tails of tau, we could show that
these intermediate regions were due to the anisotropic tumbling of the amino acids
involved. This hypothesis was confirmed by the fact that over-expression of this
fragment and affinity measurement through acrylodan labeling and FRET titration
indeed showed that the fragment bound with the same affinity as full-length tau.
Will NMR be able to give detailed structural information on how tau binds to the
MT surface? This would certainly be a first step toward understanding how it favors
the assembly of tubulin into microtubules, and also how phosphorylation regulates
this process. Working with microtubules will remain challenging, because even with
full deuteration of tau, the bound part on such large systems broadens beyond
detection. We show this in Fig. 7 with a TauF1 fragment spanning residues
169–441. Only those parts that project from the surface maintain detectable intensity.
Recently, solid state NMR has given some further insight into the Cap-Gly protein
and its interaction with microtubules (Sun et al., 2009), and might in the future
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evolve toward a technique that can handle samples of this size. However, current
believe is that working with well-defined rings or other systems in which the sample
heterogeneity due to polymerization is less problematic will be the more promising
route to answer these challenging questions.
V. Concluding Remarks
Characterizing the molecular mechanisms of MT–MAP interaction is highly rele-
vant both to understanding their biological functions and their deregulation leading to
severe pathologies such as cancer or neurodegenerative diseases. The microtubule
cytoskeleton is a network for which specific care must be taken because of the peculiar
physicochemical properties of its main constituents. Tubulin, in addition to its natural
fragility, needs to be handled with care because of its capability to self-assemble into a
wide variety of polymers; tau and stathmin cannot be traced easily because of their lack
of aromatic residues; tau is natively unstructured. All these apparent sources of concern
in a protein–protein interaction study actually became advantages to characterize the
thermodynamics of MAPs–tubulin complex formation. We used the peculiar properties
of the three proteins studied (tau, stathmin, and tubulin) to detail the most appropriate
combination of methods (AUC, ITC, FRET and NMR, as well as co-sedimentation) to
characterize the complexes formed, to determine the thermodynamic parameters of
these interactions and to detail the MAP/MT interface. This biophysical approach has
allowed us to give new insight into the molecular mechanisms that govern MAPs
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Fig. 6 HSQC spectra of a tau fragment [208–324] at 4°C and 800 MHz (left) or 20°C and 600 MHz
(right), illustrating the gain in resolution of both a lower temperature and higher field.
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action on MT network. This will not only shed new light on the role of this crucial
family of proteins in the biology of the cell, but will also hopefully open new paths to
enhance the therapeutic efficiency of microtubule-targeting drugs in cancers therapies
and neurodegenerative diseases prevention.
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